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Abstract
Background: Spontaneous bacterial peritonitis (SBP) is often difficult to diagnose because bacteria in ascites cannot
be detected accurately by conventional culture. In situ hybridization (ISH) was previously developed for rapid detection
of genes from bacteria phagocytized by neutrophils. SBP may develop after bacteria enter into the systemic circulation
following bacterial translocation. Therefore, we performed ISH to identify bacteria in blood samples collected from
patients with decompensated liver cirrhosis (LC).
Methods: In this retrospective study, peripheral blood samples were collected from 60 patients with decompensated
LC, and bacteria were detected by both blood culture and ISH. Moreover, 35 patients underwent paracentesis for
diagnosis of SBP.
Results: Eight of 35 patients were diagnosed with SBP by polymorphonuclear neutrophil counts, and one patient was
diagnosed with bacterascites. Seven of the nine patients showed positive results for ISH, whereas bacteria were
detected in only two cases by blood culture. Thirty-seven of 60 cases (62%) showed positive results for ISH, whereas
only six samples (10%) were positive by blood culture analysis. Compared with the 23 cases of negative ISH, the 37
cases of positive ISH showed a higher frequency of fever, higher Child-Pugh scores, and lower albumin levels.
Conclusions: Detection of bacteria by ISH suggested that bacterial translocation, which cannot be proven by
conventional culture, occurred in these patients, and that ISH could be helpful for the early diagnosis of
some types of infection and prevention of SBP in these patients.
Keywords: Spontaneous bacterial peritonitis, Bacterial translocation, Liver cirrhosis, In situ hybridization, Blood
culture
Background
Patients with decompensated liver cirrhosis (LC) often
suffer from various complications, such as hepatic
encephalopathy, jaundice, gastroesophageal varices, and
ascites. Spontaneous bacterial peritonitis (SBP), which
was first reported by Conn and Fessle in 1971, is associ-
ated with a poor prognosis [1–4]. Early diagnosis and
antibiotic treatment are necessary for management of SBP
[4, 5]. However, it is difficult to diagnose SBP because
bacteria in ascites or blood cannot be detected accurately
by conventional culture in a timely manner. Polymorpho-
nuclear neutrophil (PMN) counts in ascites are useful for
diagnosis of SBP, and empirical antibiotic therapy should
be started immediately after the diagnosis of SBP without
knowledge of the causative bacteria [5].
The use of in situ hybridization (ISH) for detection of
genes from bacteria phagocytized by neutrophils in asci-
tes may have applications in the diagnosis of SBP [6].
ISH was developed to detect bacteria rapidly in patients
with suspected bacterial infection [7] and can be applied
to identify bacterial genes in neutrophils directly under a
microscope after collection of blood samples from
patients. Enomoto et al. reported that ISH is highly
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sensitive for detection of bacteria in ascites from pa-
tients with SBP [6]. Indeed, SBP may develop following
bacterial translocation, during which enteric bacteria
cross the intestinal epithelial cells, reach mesenteric
lymph nodes [8], and enter into the systemic circulation
[9]. Therefore, we hypothesized that patients with SBP
may already exhibit systemic bacterial inflammation.
Accordingly, in this study, we attempted to detect
bacteria in blood samples from patients with decompen-
sated LC by ISH, and evaluated the utility of ISH com-
pared with conventional blood culture in these patients.
Methods
Patients
Patients admitted to Keio University Hospital from April
2008 to March 2011 and who underwent ISH were in-
cluded in this retrospective study. We performed ISH a
total of 110 times in 94 patients. Twenty-five cases were
patients without liver disease, and 13 cases were patients
without cirrhosis. Sixty of 72 patients had ascites and
were diagnosed with decompensated LC. Blood samples
from 60 patients diagnosed with decompensated LC
were simultaneously examined by ISH and blood cul-
ture. Moreover, 35 patients with mild or severe ascites
underwent paracentesis to diagnose SBP by PMN counts
of no less than 250/μL in ascitic samples, and ascitic
samples were investigated with the blood samples simul-
taneously (Fig. 1). This study was approved by the ethics
committee of our university hospital.
ISH
ISH was performed using a commercial kit provided by
Fuso Pharmaceuticals (Osaka, Japan). In ISH, the probes
used to detect bacterial genomes for Staphylococcus
aureus (SA), S. epidermidis (SE), Pseudomonas aerugi-
nosa (PA), Enterococcus faecalis (EF), and a group of
enterobacteria (Escherichia coli, Enterobacter cloacae,
and Klebsiella pneumoniae [EK]) were previously estab-
lished [7]. These pathogens are frequent causes of bac-
terial infections in patients with SBP [4, 10].
ISH was performed using blood samples from patients.
Briefly, heparinized blood samples from patients were cen-
trifuged (150×g for 10 min); leukocytes were collected
after hemolysis with hypotonic buffer and resuspended in
phosphate-buffered saline (PBS) at a concentration of
5 × 104 cells/μL. A sample of the cellular suspension (5–
10 μL) was spread onto a glass slide and air-dried. The
slide was fixed in Carnoy’s solution for 20 min and perme-
abilized; bacterial DNA was denatured. Digoxygenin
(Dig)-labeled probes and anti-Dig-alkaline phosphatase
(ALP) were used for detection. Intracellular Dig-labeled
hybridized signals were detected by anti-Dig-ALP. To
visualize the signals, color development was achieved
using nitro blue tetrazolium (NBT)-5-bromo-4-chloro-3-
indolyl phosphate (BCIP) as a substrate for ALP. Positive
signals in the cell cytoplasm were observed under a micro-
scope. Blue-colored dots in neutrophils, representing
phagocytic bacteria, were assumed to represent a positive
result.
Blood and ascitic cultures
All blood and ascitic samples were collected into both
aerobic and anaerobic blood culture bottles. Blood and
ascitic culture bottles were sent to the reference micro-
biology laboratory of our hospital for processing. The
blood culture system BD Bactec FX (Nippon Becton
Dickinson, Tokyo, Japan) was used for the detection of
pathogens. Samples were incubated at 37 °C for 5 days.
Fig. 1 Algorithm for cases performed by ISH. We performed ISH 110 times for 94 cases. Twenty-five cases were patients without liver diseases,
and 13 cases did not exhibit cirrhosis. Twelve of 72 patients with liver cirrhosis were examined with ISH only; thus, 60 samples were included in
this study
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Isolates of microorganisms were identified using a Bac-
tec FX system.
Statistical analysis
Comparisons of the frequencies between the two groups
were analyzed by McNemar’s tests. Baseline data for pa-
tients with LC were statistically evaluated. Variables were
expressed as the mean ± standard deviation (SD), and
differences between two groups were evaluated by
Student’s t-tests, and three groups by ANOVA.
Results
Patient background
Table 1 shows the characteristics of the 60 patients
included in this study. ISH and conventional blood cul-
tures were performed in 60 patients with ascites out of
72 decompensated LC patients. The median age was
62 years, and the patients were predominantly male
(male:female = 35:25). The causes of cirrhosis were
hepatitis B virus infection (n = 4), hepatitis C virus infec-
tion (n = 18), alcohol (n = 21), and other factors
(n = 17). All patients had ascites, and their Child-Pugh
scores were no less than 8. The Child-Pugh classifica-
tions were B and C, and the mean score was 9.97 ± 1.55.
The median total bilirubin value was 2.85 mg/dL, and
the maximum value was 29.2 mg/dL. The mean albumin
and creatinine values were 2.41 ± 0.47 mg/dL and
1.18 ± 0.71 g/dL, respectively. The median Model For
End-Stage Liver Disease (MELD) score was 15. Patients
with diabetes were those who were diagnosed as such by
fasting blood glucose or oral glucose tolerance test and
treated with insulin or hypoglycemic drugs.
Comparison between ISH and blood cultures in patients
undergoing paracentesis
Eight cases were diagnosed with SBP based on PMN
counts. The diagnosis of SBP was based on elevated
PMN counts (≥ 250/μL) in 35 cases undergoing paracen-
tesis (Fig. 2). ISH results were positive in six of eight
SBP cases, whereas only one case was positive for blood
culture. One patient who was positive for ascitic culture
was also positive for ISH but negative for blood culture.
In seven ascitic culture-negative cases, five were positive
for ISH, and one was positive for blood culture. One
patient was diagnosed with bacterasites and showed
positive results for both ISH and blood culture. Of note,
14 of 27 patients who were not diagnosed with SBP by
PMN counts of ascites were positive for ISH, and three
out of 14 patients later proved to be positive for blood
culture, suggesting that ISH might be useful to diagnose
bacterial infection in decompensated LC patients earlier
than conventional ways. We did not find any cases who
were negative for ISH but positive for ascitic cultures or
blood cultures.
Differences in detection rates between ISH and blood
culture
Of the 60 cases who underwent both ISH and blood
culture, six were positive for bacteremia by blood culture
(10.0%), whereas 37 were positive by ISH (61.7%;
p < 0.001; Table 2). The rate of positive detection by ISH
was significantly higher than that by blood culture. All
positive cases by blood culture were positively detected
by ISH, and no cases were negative for ISH but positive
for blood culture.
Clinical features and detection of ISH
Thirty of the 60 patients had fever. Among the patients
with fever, 23 cases (76.7%) were positive for ISH ana-
lysis, and six (20.0%) were positive for blood cultures.
Among the patients without fever, 14 cases (46.7%) were
positive for ISH analysis, but none was positive for blood
cultures. In 47 C-reactive protein (CRP)-positive cases
(≥ 1 mg/dL), 30 (63.8%) and four (8.5%) cases were posi-
tive for ISH analysis and blood cultures, respectively.
The rates of positive results between ISH and blood
cultures differed significantly, suggesting that ISH may
detect bacteria more sensitively than conventional blood
culture (Table 3). Among 24 patients with antibiotic use,
oral or intravenous antibiotic treatment was given to 22
patients for confirmed or suspected bacterial infections
with unidentified origin. Two patients received an oral
Table 1 Baseline characteristics of patients with cirrhosis who
underwent ISH
Mean ± SD or median value (range)
Age (years) 62 (29–84)
Sex (male/female) 35/25
Etiology (HBV/HCV/alcohol/others) 4/18/21/17
Child-Pugh classification (B/C) 23/37
Child-Pugh score 9.97 ± 1.55
Total bilirubin (mg/dL) 2.85 (0.3–29.2)
Albumin (g/dL) 2.41 ± 0.47
Prothrombin time (INR) 1.38 (0.97–2.38)
Creatinine (mg/dL) 1.18 ± 0.71
White blood cell counts (/μL) 6350 (2000–27,800)
Platelet counts (× 103/μL) 78.5 (20–760)
C-reactive protein (mg/dL) 2.42 (0.12–15.53)
MELD score 15 (7–34)
Esophageal varices (+/−) 36/24
Hepatocellular carcinoma (+/−) 19/41
Abdominal pain (+/−) 4/56
Diabetes mellitus (+/−) 17/43
Valuables are the mean ± standard deviations (SDs) or median (range)
HBV: hepatitis B virus, HCV: hepatitis virus
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aminoglycoside bactericidal antibiotic called kanamycin
for prevention of SBP. It is possible that using antibiotics
in these patients possibly affected the sensitivity of blood
culture.
Moreover, we compared the clinical characteristics
between ISH/blood culture positive (+/+), ISH positive-
blood culture negative (+/−), and both negative (−/−) pa-
tients (Table 4). There were significant differences in the
frequency of clinical symptom of fever between the three
groups (p < 0.05), suggesting that ISH or the combin-
ation of ISH and blood culture is useful for the early
diagnosis of bacterial infection. Further study in a larger
sample size is needed to validate the results.
Detection of bacterial groups by ISH
Table 5 shows the DNA probes used for detection of
bacteria in ISH and the number of positive cases by each
probe. The EK probe was positive in almost all cases
(81%). Eight cases showed positive ISH results for the
EK probe and another probe simultaneously.
Discussion
In this study, we successfully employed ISH to detect
pathogens in the blood from patients with decompen-
sated LC in whom blood culture results were negative
for bacterial infection. These findings suggested that
bacterial translocation cannot be always detected by
conventional blood culture because SBP is known to
occur after bacterial translocation, defined as the passage
of bacteria from the intestine or colon through the intes-
tinal epithelial cells and entrapment in the mesenteric
lymph nodes [8, 11]. After bacterial translocation,
bacteria are thought to enter the systemic bloodstream
and access ascitic fluid, which exhibits low bactericidal
capacity [9, 12–14]. Bacterial translocation has been
demonstrated in some studies in both human and ani-
mal models of LC [15, 16]. However, it is unclear how
SBP develops from bacterial translocation because this
event cannot be detected easily by conventional blood
Fig. 2 Algorithm of patients who received paracentesis. Eight of 35 patients were diagnosed with spontaneous bacterial peritonitis (SBP). Six
cases of SBP (75.0%) were positive for bacteremia by ISH, but only one patient (12.5%) was positively identified by blood bottle culture




ISH Positive 6 (10.0%) 31 (51.7%) 37 (61.7%)
Negative 0 (0%) 23 (38.3%) 23 (38.3%)
Total 6 (10.0%) 54 (90.0%) 60 (100%)
Table 3 Positive detection rates by ISH and blood cultures






Total 60 37 (61.7%) 6 (10.0%) < 0.001
Fever 30 23 (76.7%) 6 (20.0%) < 0.001
No fever 30 14 (46.7%) 0 (0.0%) –
CRP ≥ 1 mg/dL 47 30 (63.8%) 4 (8.6%) < 0.001
CRP < 1 mg/dL 13 7 (53.8%) 2 (15.4%) 0.0253
Antibiotic use 24 15 (62.5%) 2 (8.3%) < 0.001
Statistical significance was determined by McNemar’s test
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culture [11]. Such et al. reported that bacterial DNA
can be detected simultaneously in blood and ascitic
fluid [17, 18], using a polymerase chain reaction (PCR)-
based method. Although this method may provide
evidence of the relationship between bacterial trans-
location and SBP, no studies have compared PCR-based
methods with blood culture. Therefore, we hypothe-
sized that ISH could be applied to decompensated LC
patients to detect bacteria and may be helpful for
selecting patients who may have an infection earlier
and determining the proper antibiotic to use if bacteria
are present in the systemic bloodstream after bacterial
translocation.
ISH was first developed to enable early diagnosis of
sepsis within 1 day, using ISH of the bacterial genomes
existing in neutrophils after phagocytosis. This method
was reported to be four times as sensitive as blood cul-
ture for detection of bacteria in patients with sepsis [7].
The other advantages of the ISH method are that it can
eliminate potential contamination and is not affected by
antibiotic use, as it analyzes pathogens already captured
into neutrophils by phagocytosis. Thus, the probability
of false-positive results is low with this procedure.
Enomoto et al. developed a new probe mixture, desig-
nated a global bacteria (GB) probe, which was capable of
detecting all relevant bacterial strains. Using ISH, this
probe showed positive results in 10 of 11 SBP cases and
negative results in none of 40 non-SBP cases in ascites
[6]. Bacteria causing SBP are frequently gram-negative
rods, such as Escherichia coli and K. pneumoniae, or can
be Streptococcus species [10]. Such et al. studied bacter-
ial DNA to show that Escherichia coli were the most
frequently identified bacteria [18]. This is consistent with
our results demonstrating that Enterobacteria were
frequently detected. Therefore, even five specific probes
without the global bacteria probe may be useful for de-
tection of bacteria in patients with decompensated LC.
These results suggest that early detection of specific bac-
teria causing SBP and early therapeutic intervention
using appropriate antibiotics are additional advantages
of ISH for patients with LC and SBP. However, fur-
ther studies are needed to confirm this assumption.
Additionally, blood cultures beyond ISH tests are
thought to be necessary for such patients because
bacteria other than the five species probed by ISH
may be detected and because drug susceptibility tests
cannot be performed by ISH.
Interestingly, in our study, some clinical parameters
were related to the results of ISH tests, including the
presence of fever and Child-Pugh scores. These results
may also be related to the occurrence of bacterial trans-
location. Cirera et al. detected enteric organisms increas-
ingly from mesenteric lymph nodes in patients with or
without cirrhosis according to the Child-Pugh score:
3.4% in A, 8.1% in B, and 30.8% in C [15]. Bacteria in
neutrophils were detected in 47% of patients without
Table 4 Comparison of clinical manifestations among positive (+/+), ISH positive-blood culture negative (+/−), and fully negative
(−/−) patients
ISH/blood culture (+/+) (+/−) (−/−) P value
No. 6 31 23
Fever (+) 6 (10 0%) 17 (55%) 7 (30%) < 0.001
CRP (mg/dL) 3.40 ± 1.44 3.98 ± 0.63 2.92 ± 0.75 N.S.
Child-Pugh score 11.3 ± 0.6 10.1 ± 0.3 9.4 ± 0.3 0.020
MELD score 18.0 ± 2.6 17.4 ± 1.1 15.6 ± 1.3 N.S.
Total bilirubin (mg/dL) 7.62 ± 2.97 6.85 ± 1.30 4.34 ± 1.51 N.S.
Albumin (g/dL) 2.17 ± 0.19 2.33 ± 0.08 2.58 ± 0.10 N.S.(0.066)
Prothrombin time (INR) 1.49 ± 0.11 1.40 ± 0.05 1.38 ± 0.06 N.S
Platelet counts (× 103/μL) 68.8 ± 45.2 99.7 ± 19.9 134.7 ± 23.1 N.S.
Diabetes mellitus (+) 4 (67%) 9 (29%) 4 (17%) 0.049
HCC (+) 4 (67%) 7 (23%) 8 (35%) N.S.
Esophageal varix (+) 4 (67%) 18 (58%) 14 (61%) N.S.
Table 5 Bacterial strains detected by ISH
Bacteria ISH probe Number of positive cases
Escherichia coli
Enterobacter cloacae EK 30 (81.1%)
Klebsiella pneumoniae
Enterococcus faecalis EF 6 (16.2%)
Staphylococcus aureus SA 5 (13.5%)
Pseudomonas aeruginosa PA 4 (10.8%)
Staphylococcus epidermidis SE 0 (0.0%)
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fever and in 54% of patients whose CRP levels were
below 1 mg/dL in our study. Surprisingly, bacterial
translocation may already be present in asymptomatic
patients with LC having ascites. Evans et al. reported
that 3.5% of all outpatients with cirrhosis had SBP, and
1.9% of these patients had bacterascites [19]. Moreover,
several studies have also demonstrated that more severe
liver failure is associated with lower CRP levels [20, 21].
Administration of antibiotics may be considered to pre-
vent further deterioration of sepsis or SBP in decompen-
sated LC patients positive for ISH; these patients have
no clinical symptoms at this point.
Recent reports have shown that serum albumin
functions to maintain oncotic pressure and has im-
munomodulatory and antioxidant effects. Albumin
infusions were found to reduce the incidence of renal
failure and mortality in patients with SBP [22, 23].
Patients with positive results by ISH had higher
Child-Pugh scores and showed a tendency of lower
serum albumin levels (Table 4). If hypoalbuminemia
indicates immunological deterioration in patients with
decompensated LC, patients who are positive for ISH
may be required to receive albumin infusions early in
addition to antibiotics.
The limitations of this study include the small number
of subjects. Obviously, a larger controlled study will be
needed to validate the results and confirm the usefulness
of ISH.
Conclusions
In conclusion, bacterial translocation, which often occurs
in ascitic patients with LC, cannot be proven by methods
such as conventional blood cultures. ISH may be helpful
to select patients who are suspected of having an infec-
tion, including SBP, and to manage treatment in a timely
manner, although additional studies are required.
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